Newborn Screening Market Analysis, Market Size, Regional Outlook, Competitive Strategies and Forecasts, 2022
According to Stratistics
MRC, the Global Newborn Screening Market is accounted from $599.77 million in
2016 to reach $1395.65 million by 2023 with a CAGR of 12.7%. Increasing
chromosomal abnormalities in infants, growing awareness in urbanized nations
and rising panel of newborn infections are some of the key factors fueling the
market growth. However, lack of specialized infrastructure and socio- economic
barriers in emerging countries are hindering the growth of the market.
Government initiatives and screening of aging disorder provides ample
opportunities for the market growth.
Newborn screening is the
practice of testing all babies in their starting stage of life for certain
disorders and situations that can delay their normal growth. This testing is
necessary in each state and is normally performed before the baby leaves the
hospital. The circumstances included in newborn screening can cause severe
health problems starting in infancy or childhood. Early detection and treatment
can help out to avoid intellectual and physical disabilities and life
threatening illnesses.
By test type, Dried Blood Spot (DBS) testing is a simple method of collecting, shipping and storing blood samples. DBS sampling has been used for clinical and pre-clinical pharmacokinetic studies, taking advantage of smaller sampling needs and simplified sample collection and handling. DBS sampling has also been used for disease surveillance in emerging nations.
North America captured the largest market share owing to the increasing awareness and increasing prevalence of cardiovascular disorders. Asia-Pacific region is expected to grow at a faster rate during the forecast period due to rising fertility rates and newborn death rates in the region.
Some of the key players in Newborn Screening market include Perkinelmer, Inc., Natus Medical Incorporated, Agilent Technologies Inc., Covidien PLC, Trivitron Healthcare, AB Sciex LLC, Masimo Corporation, GE Healthcare, Waters Corporation, Bio-Rad Laboratories, Inc., Bio Tek Instruments, Inc., Cardinal Health, Inc., Medtronic Plc, Thermo Fisher Scientific, Inc., Zen Tech S.A. and Neogen Labs Pvt. Ltd.
Technologies Covered:
Electrophoresis
DNA-Based Assays
Pulse Oximetry Screening Technology
Tandem Mass Spectrometry (TMS)
Immunoassays and Enzymatic Assays
Hearing Screen Technology
By test type, Dried Blood Spot (DBS) testing is a simple method of collecting, shipping and storing blood samples. DBS sampling has been used for clinical and pre-clinical pharmacokinetic studies, taking advantage of smaller sampling needs and simplified sample collection and handling. DBS sampling has also been used for disease surveillance in emerging nations.
North America captured the largest market share owing to the increasing awareness and increasing prevalence of cardiovascular disorders. Asia-Pacific region is expected to grow at a faster rate during the forecast period due to rising fertility rates and newborn death rates in the region.
Some of the key players in Newborn Screening market include Perkinelmer, Inc., Natus Medical Incorporated, Agilent Technologies Inc., Covidien PLC, Trivitron Healthcare, AB Sciex LLC, Masimo Corporation, GE Healthcare, Waters Corporation, Bio-Rad Laboratories, Inc., Bio Tek Instruments, Inc., Cardinal Health, Inc., Medtronic Plc, Thermo Fisher Scientific, Inc., Zen Tech S.A. and Neogen Labs Pvt. Ltd.
Technologies Covered:
Electrophoresis
DNA-Based Assays
Pulse Oximetry Screening Technology
Tandem Mass Spectrometry (TMS)
Immunoassays and Enzymatic Assays
Hearing Screen Technology
Full report with Table of
Content: https://marketreportscenter.com/reports/571482/newborn-screening-global-market-outlook-2017-2023
Product Types Covered:
Reagents and Assay Kits
Instruments
Test Types Covered:
Hearing Screen Test
Dry Blood Spot Test
Critical Congenital Heart Diseases (CCHD) Test
End-Users Covered:
Ambulatory Care
Hospitals
Nursing Homes
Diseases Covered:
Hearing Disability
Blood Spot Disease
Thyroid Disorder
Sickle Cells Disease
Maple Syrup Disease
Critical Congenital Cardiac Disease
Reagents and Assay Kits
Instruments
Test Types Covered:
Hearing Screen Test
Dry Blood Spot Test
Critical Congenital Heart Diseases (CCHD) Test
End-Users Covered:
Ambulatory Care
Hospitals
Nursing Homes
Diseases Covered:
Hearing Disability
Blood Spot Disease
Thyroid Disorder
Sickle Cells Disease
Maple Syrup Disease
Critical Congenital Cardiac Disease
…
About
Market Reports Center;
Market Reports Center is an e-commerce platform
obliging the needs of knowledge workers, experts, professionals who are subject
to market research information for their work, or to make strategic business
decisions. We are dedicated to create a comprehensive offering of market
research which is accurate, credible and affordable.
Connect
for more details:
Sam
Collins
Market
Reports Center
1-646-883-3044
(US)
Comments
Post a Comment